The new antidepressant vortioxetine (Brintellix) is more efficacious than placebo, but whether it has added benefits that will justify its higher cost compared with generic antidepressants has yet to be determined.
Vitamin D and Psychiatric Patients
Patients with chronic mental illness who are deficient in vitamin D should receive nutritional supplements.
Antipsychotics in Dementia: Another Look
Higher doses of antipsychotic drugs seem to increase the risk of death in patients with dementia, but lower doses might not.
Both Benzodiazepines and Nonbenzodiazepine Hypnotic Medications Are Associated with an Increased Risk of Fractures
Please be sure to review the Continuing Medical Education (CME) posttest and evaluation for 2013, inserted in this month's issue.
Pharmacogenomics may soon provide the key to personalizing medication treatments for each individual patient.
About the BTP Newsletter
Our subscribers say BTP is…
"Very relevant, practical, and thought-provoking."
"About the only thing left without drug ads...objective and balanced."
"Succinct, readable, clear, timely and relevant!"
"Well written and scientifically sound."
Originating at the Massachusetts General Hospital and Harvard Medical School, Biological Therapies in Psychiatry has been a trusted resource for physicians for over 30 years. Described as "influential" by the Atlantic Monthly, this concise, four-page, monthly newsletter provides up-to-date information about the rapidly expanding field of psychotropic medications and other biological treatments for mental disorders.
From his perspective as an editor, teacher, investigator, and clinician, Alan J. Gelenberg, M.D., reviews the widespread literatures of science and clinical practice. Dr. Gelenberg distills the material most relevant for a busy practitioner and presents it each month with a balance of scientific curiosity, healthy skepticism, and clinical experience.
Dr. Gelenberg is Professor and Interim Chair of Psychiatry at Penn State, Hershey. Since 1987, Dr. Gelenberg has been Editor-in-Chief of the Journal of Clinical Psychiatry, and he recently chaired the workgroup that revised the American Psychiatric Association's major depressive disorder guidelines. Dr. Gelenberg has been on the faculty of Harvard Medical School, MIT, and the University of Arizona and has written numerous scientific articles and book chapters on mood disorders, depression, and schizophrenia. He is listed in the Best Doctors in America and America's Top Doctors and received the 1997 Exemplary Psychiatrist Award of the National Alliance for the Mentally Ill.
We offer both print and online subscriptions. Our web site provides subscribers with 24-hour access to archives as well as current issues. In addition, Continuing Medical Education credit is available for reading BTP. You can earn up to 12.0 hours in category 1 credit by answering questions in the December issue about topics covered during the year.